ACS Omega,
Journal Year:
2022,
Volume and Issue:
8(1), P. 976 - 986
Published: Dec. 28, 2022
Codelivery
of
chemotherapeutic
drugs
in
nanoparticles
can
enhance
the
therapeutic
effects
against
tumors.
However,
their
anticancer
properties
and
physiochemical
characteristics
be
severely
influenced
by
many
formulation
parameters
during
preparation
process.
It
is
a
complicated
development
phase
to
select
optimal
for
based
on
commonly
used
one
single
parameter
method,
which
consumes
lot
money,
time,
effort,
sometimes
even
fails.
Therefore,
statistical
analysis
Box-Behnken
design
(BBD)
has
attracted
much
attention
bioengineering
fields
because
it
illustrate
influence
parameters,
build
mathematical
models,
predict
combinational
factors
decreased
number
experiments.
In
this
study,
we
three-factor
three-level
BBD
optimize
poly(lactic-co-glycolic
acid)
(PLGA)
coloaded
with
two
curcumin
paclitaxel
(PLGA-CUR-PTX
nanoparticles).
The
surfactant
concentration,
polymer
oil-water
ratio
were
selected
as
independent
variables.
An
optimized
model
PLGA-CUR-PTX
was
validated.
possessed
uniform
spherical
shape,
an
average
size
99.94
nm,
drug
encapsulation
efficiencies
CUR
PTX
63.53
80.64%,
respectively.
release
from
showed
biphasic
behavior,
mechanism
via
diffusion
fundamentally
quasi-Fickian
diffusion.
demonstrated
enhanced
cytotoxicity
effect
lower
IC50
values
4T1
MCF-7
breast
cancer
cell
lines
compared
free
drugs.
summary,
optimization
yielded
favorable
carrier
that
holds
potential
alternative
treatment
therapy.
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2025,
Volume and Issue:
14
Published: Jan. 20, 2025
Messenger
RNA
(mRNA)
vaccines
offer
an
adaptable
and
scalable
platform
for
cancer
immunotherapy,
requiring
optimal
design
to
elicit
a
robust
targeted
immune
response.
Recent
advancements
in
bioinformatics
artificial
intelligence
(AI)
have
significantly
enhanced
the
design,
prediction,
optimization
of
mRNA
vaccines.
This
paper
reviews
technologies
that
streamline
vaccine
development,
from
genomic
sequencing
lipid
nanoparticle
(LNP)
formulation.
We
discuss
how
accurate
predictions
neoantigen
structures
guide
sequences
effectively
target
cells.
Furthermore,
we
examine
AI-driven
approaches
optimize
mRNA-LNP
formulations,
enhancing
delivery
stability.
These
technological
innovations
not
only
improve
but
also
enhance
pharmacokinetics
pharmacodynamics,
offering
promising
avenues
personalized
immunotherapy.
Pharmaceuticals,
Journal Year:
2023,
Volume and Issue:
16(2), P. 283 - 283
Published: Feb. 13, 2023
Oral
delivery
has
become
the
route
of
choice
among
all
other
types
drug
administrations.
However,
typical
chronic
disease
drugs
are
often
poorly
water-soluble,
have
low
dissolution
rates,
and
undergo
first-pass
metabolism,
ultimately
leading
to
bioavailability
lack
efficacy.
The
lipid-based
formulation
offers
tremendous
benefits
using
versatile
excipients
great
compatibility
with
dosage
forms.
Self-microemulsifying
system
(SMEDDS)
promotes
self-emulsification
in
a
combination
oil,
surfactant,
co-surfactant,
thereby
facilitating
better
solubility
absorption.
feasible
preparation
SMEDDS
creates
promising
strategy
improve
drawbacks
lipophilic
administered
orally.
Selecting
decent
mixing
these
components
is,
therefore,
importance
for
successful
SMEDDS.
Quality
by
Design
(QbD)
brings
systematic
approach
development,
it
promise
significantly
manufacturing
quality
performance
Furthermore,
could
be
benefited
efficiently
conducting
pre-formulation
studies
integrated
statistical
design
experiment
(DoE).
In
this
review,
we
highlight
recent
findings
development
microemulsions
DoE
methods
optimize
formulations
different
controllable
ratios.
A
brief
overview
concepts
is
discussed,
along
its
technical
improving
formulations.
Deleted Journal,
Journal Year:
2024,
Volume and Issue:
6(8)
Published: July 29, 2024
Abstract
Arteriosclerosis
(AS)
presents
a
significant
global
health
challenge,
demanding
innovative
therapeutic
strategies.
This
review
explores
the
potential
of
nanoparticles
(NPs)
and
mesenchymal
stem
cells
(MSCs)
as
promising
modalities
for
treating
AS.
NPs
enable
targeted
drug
delivery,
while
MSCs
possess
immunomodulatory
regenerative
capabilities.
We
discuss
recent
advances
in
NP-based
delivery
systems
tailored
AS
treatment
highlight
MSCs’
roles
modulating
inflammation
promoting
vascular
repair.
Additionally,
we
examine
synergistic
effects
combining
enhanced
outcomes.
Furthermore,
this
paper
provides
insights
into
targeting
endothelial
cells,
T-cells,
macrophages,
lipid
levels,
plaques
using
MSCs.
It
also
reviews
various
types
metal-based
non-metallic
utilized
therapy.
comprehensive
overview
underscores
synergies
between
cardiovascular
disease
therapy,
emphasizing
need
further
research
to
fully
realize
their
implications.
Graphical
International Journal of Pharmaceutics,
Journal Year:
2025,
Volume and Issue:
671, P. 125202 - 125202
Published: Jan. 10, 2025
Over
the
past
two
decades,
extensive
research
has
focused
on
both
fundamental
and
applied
aspects
of
nanomedicine,
driven
by
compelling
advantages
that
nanoparticles
offer
over
their
bulk
counterparts.
Despite
this
intensive
effort,
fewer
than
100
nanomedicines
have
been
approved
U.S.
Food
Drug
Administration
European
Medicines
Agency
since
1989.
This
disparity
highlights
a
substantial
gap
in
translational
research,
reflecting
disconnect
between
prolific
nanomedicine
limited
number
products
successfully
reach
sustain
themselves
market.
For
instance,
DepoCyt,
which
received
FDA
approval
1999
for
treatment
lymphomatous
meningitis,
was
discontinued
2017
due
to
persistent
manufacturing
issues.
To
address
similar
challenges,
review
aims
identify
analyse
issues
related
formulation
design
nanomedicines.
It
provides
an
overview
most
prevalent
technologies
excipients
used
production,
followed
critical
evaluation
clinical
translatability.
Furthermore,
presents
strategies
rational
optimization
manufacturing,
adhering
principles
quality-by-design
quality
risk
management.
Magnetic
nanoparticles
(NPs)
are
gaining
significant
interest
in
the
field
of
biomedical
functional
nanomaterials
because
their
distinctive
chemical
and
physical
characteristics,
particularly
drug
delivery
magnetic
hyperthermia
applications.
In
this
paper,
we
experimentally
synthesized
characterized
new
Fe3O4-based
NPs,
functionalizing
its
surface
with
a
5-TAMRA
cadaverine
modified
copolymer
consisting
PMAO
PEG.
Despite
these
advancements,
many
combinations
NP
cores
coatings
remain
unexplored.
To
address
this,
created
data
set
systems
from
public
sources.
Herein,
11
different
AI/ML
algorithms
were
used
to
develop
predictive
models.
The
linear
discriminant
analysis
(LDA)
random
forest
(RF)
models
showed
high
values
sensitivity
specificity
(>0.9)
training/validation
series
3-fold
cross
validation,
respectively.
able
predict
14
output
properties
(CC50
(μM),
EC50
inhibition
(%),
etc.)
for
all
54
classes
vs.
25
coats
41
cell
lines,
allowing
short
listing
best
results
experimental
assays.
work
may
help
reduce
cost
traditional
trial
error
procedures.
European Polymer Journal,
Journal Year:
2022,
Volume and Issue:
173, P. 111307 - 111307
Published: May 25, 2022
The
design
of
polymeric
nanoparticles
(PNPs)
for
delivery
and
controlled
release
drugs
has
been
increasing
in
the
last
decades,
where
materials
such
as
biocompatible
degradable
polyesters
have
advantages.
However,
it
is
necessary
to
control
modulate
size
(NPs)
prevent
uptake
clearance
by
reticuloendothelial
system
achieve
selective
on
a
pharmaceutical
target.
In
this
mediation,
modulation
particle
(PS)
polydispersity
index
(PDI)
one
most
sought
parameters.
work,
study
external
parameters
power,
time,
cycles
sonication
preparation
with
polylactic
acid
(PLA)
simple
emulsion-solvent
evaporation
(SE-SE)
technique
using
ultrasound
was
carried
out.
A
Box-Behnken
method
used
improve
optimize
conditions
obtaining
nanoformulation,
which
allowed
response
surfaces
figure
out
effect
PS,
PDI,
ζ-Potential.
This
showed
that
main
influential
parameter
PDI
followed
time
sonication,
finally,
number
cycles.
statistical
model
prediction
variables
obtain
diameters
between
110
240
nm,
0.09–0.32,
ζ-Potential
remained
relatively
constant
each
experiment
an
average
value
−21.0
mV.
adequate
preparing
PNPs
are
20%
power
employed,
20
s
two
pause
10
pulse
when
PLA
136
kDa
used.
optimized
NPs
were
144.5
±
0.5
nm
0.1347
0.0064,
respectively.
Additionally,
can
develop
desired
PS
nanoformulations
excellent
homogeneity.